Intention to Treat

New Hope for a Common and Deadly Heart Condition


Listen Later

This episode considers a new treatment for hypertrophic cardiomyopathy, the world’s most common inherited heart condition, which most affected people don’t even realize they have.

A full transcript of this episode is available at nejm.org/doi/full/10.1056/NEJMp2400702.

...more
View all episodesView all episodes
Download on the App Store

Intention to TreatBy NEJM Group

  • 4.7
  • 4.7
  • 4.7
  • 4.7
  • 4.7

4.7

31 ratings


More shows like Intention to Treat

View all
JAMA Editors' Summary by JAMA Network

JAMA Editors' Summary

139 Listeners

NEJM Interviews by NEJM Group

NEJM Interviews

127 Listeners

NEJM Journal Watch Podcasts: Clinical Conversations by NEJM Group

NEJM Journal Watch Podcasts: Clinical Conversations

59 Listeners

NEJM This Week by NEJM Group

NEJM This Week

322 Listeners

This Week in Cardiology by Medscape

This Week in Cardiology

873 Listeners

JAMA Clinical Reviews by JAMA Network

JAMA Clinical Reviews

507 Listeners

Hidden Brain by Hidden Brain, Shankar Vedantam

Hidden Brain

43,883 Listeners

The Daily by The New York Times

The Daily

111,156 Listeners

Eagle's Eye View: Your Weekly CV Update From ACC.org by American College of Cardiology

Eagle's Eye View: Your Weekly CV Update From ACC.org

136 Listeners

Leadership Conversations by NEJM Group

Leadership Conversations

6 Listeners

Curbside Consults by NEJM Group

Curbside Consults

89 Listeners

Annals On Call Podcast by American College of Physicians

Annals On Call Podcast

197 Listeners

The Clinical Problem Solvers by The Clinical Problem Solvers

The Clinical Problem Solvers

516 Listeners

Harrison's PodClass: Internal Medicine Cases and Board Prep by AccessMedicine

Harrison's PodClass: Internal Medicine Cases and Board Prep

362 Listeners

Hard Fork by The New York Times

Hard Fork

5,490 Listeners

The Rest Is History by Goalhanger

The Rest Is History

13,541 Listeners

NEJM AI Grand Rounds by NEJM Group

NEJM AI Grand Rounds

55 Listeners

Not Otherwise Specified by NEJM Group

Not Otherwise Specified

45 Listeners